{"id":4169,"date":"2020-12-23T11:37:15","date_gmt":"2020-12-23T16:37:15","guid":{"rendered":"https:\/\/lions.financial\/?p=4169"},"modified":"2022-11-29T16:34:33","modified_gmt":"2022-11-29T21:34:33","slug":"axa-venture-partners","status":"publish","type":"post","link":"https:\/\/lions.financial\/hi\/axa-venture-partners\/","title":{"rendered":"AXA Venture Partners"},"content":{"rendered":"

What is AXA Venture Partners\u2019 (AVP)?<\/strong><\/h1>\n

AXA Venture Partners\u2019 (AVP) is a global technology venture capital firm. Its target sectors include enterprise software, fintech\/insurtech, consumer technologies, and digital health.<\/p>\n

What are the investments in venture capital deals?<\/strong><\/p>\n

Based on Crunchbase, the majority of investments are in the software and technology industry. Other invested industry includes health care, financial services and machine learning, etc.<\/p>\n

Figure 1:Investment by Number of Investments<\/p>\n

\"A<\/p>\n

What are the investment strategies of AVP?<\/strong><\/p>\n

The company implements two types of investment strategies, direct investment and fund of funds. AVP has finished 3 rounds of funding as of January 2019 to support these investment strategies. AXA Strategic Ventures Fund I, a \u20ac200m venture capital fund for investment in innovations relevant to insurance, asset management, financial technology and healthcare service industries. A Diversified fund with $175m in a fund-of-funds scheme for investments in selected VC funds. \u00a0AVP Early Stage II, a $150 million early-stage fund.<\/p>\n

Under direct investments, Early Stage portfolio includes companies such as BioBeats (\u00a31.6 million), Blockstream ($55 million series A funding) and Hint ($10 million series A funding), Early Stage portfolio accounts for the majority of AVP\u2019s direct investment. In addition, AVP\u2019s Growth Equity portfolio includes companies such as Cognism ($12 million funding), Contrast Security ($30 million series C funding) and Force Manageer ($12 million series B funding).<\/p>\n

Figure 2:Overview of Investment Strategies<\/p>\n

\"A<\/p>\n

<\/a>What is the relationship between AXA and AXA Venture Partners? <\/strong><\/h1>\n

AXA Venture Partners is backed by AXA, the insurance, and asset manager. By connecting with AXA, AVP has access to AXA\u2019s expertise insurance and asset management industry, and AXA acts as a potential customer, partner, and distributor of AVP. For example, AVP\u2019s portfolio companies have access to additional support, such as AXA\u2019s team (Risk managers, financial advisors, and data scientists), network, and client base. AXA\u2019s lines of expertise include property & casualty, life & savings, health, and asset management which can provide a distinctive business portfolio for AVP. This relationship between AXA and AXA Venture Partners is a key value proposition of AVP.<\/p>\n

Before 2018, AVP was known as AXA Strategic Ventures.<\/p>\n

<\/a>What is Corporate Venture Capital?<\/strong><\/h1>\n

AXA Venture Partners can be referred to as corporate venture capital (CVCs). One type of venture capital funds comes from large corporations like AXA. Corporate venture capital is becoming increasingly common in the venture capital industry. Many large corporations like AXA are setting up their venture capital fund.<\/p>\n

<\/a>What is the benefit of Corporate Venture Capital?<\/strong><\/h2>\n

As a corporate venture capital, AXA Venture Partners can gain the following benefits.<\/p>\n